Cover Image
市場調查報告書

EpiCast Report:異位性皮膚炎的流行病學的預測

EpiCast Report: Atopic Dermatitis - Epidemiology Forecast to 2024

出版商 GlobalData 商品編碼 274740
出版日期 內容資訊 英文 42 Pages
訂單完成後即時交付
價格
Back to Top
EpiCast Report:異位性皮膚炎的流行病學的預測 EpiCast Report: Atopic Dermatitis - Epidemiology Forecast to 2024
出版日期: 2015年10月06日 內容資訊: 英文 42 Pages
簡介

由於異位性皮膚炎(特異反應性性濕疹)是慢性且復發的皮膚疾病,而成了全球保健衛生上的一大隱憂,特別是幼兒得病率高達10∼20%(成人為1∼2%)。全球主要9個國家的患病人數,預料2014年將達到6,628萬人,2024年達到6,763萬人。

本報告提供全球主要國家的異位性皮膚炎的發病情形與今後預測相關分析,提供您疾病的特徵,及目前患病者的發病情形,今後10年的患病數量預測值等調查評估,將結果為您概述為以下內容。

第1章 目錄

第2章 簡介

  • 概要
  • 相關調查
  • 近期出版的調查

第3章 流行病學

  • 疾病的背景
  • 風險要素和併發症
    • 風險要素
      • 10歲以下兒童,異位性皮膚炎的發病可能性有3倍高趨勢
      • 家族病史;雙親有家族病史,異位性皮膚炎的發病可能性為4倍,父母皆有則高達6倍
      • 食品及環境的過敏原,提高異位性皮膚炎的發病風險
      • 至少在生後3個月以母乳保育,可保護嬰兒不得異位性皮膚炎
    • 併發症
      • 容易併發氣喘·過敏性鼻炎·過敏性結膜炎,與異位性皮膚炎
      • 異位性皮膚炎的患者,精神疾病發病的可能性高
  • 全球各國趨勢
    • 美國
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 英國
    • 日本
    • 中國
    • 印度
  • 預測手法
    • 利用之資訊來源
    • 未利用之資訊來源
    • 預測的前提條件與手法
  • 異位性皮膚炎的流行病學的預測(今後10年份)
    • 異位性皮膚炎的一生患病人數
    • 異位性皮膚炎的一生患病人數:各年齡
    • 異位性皮膚炎的一生患病人數:男女
    • 年齡已調整的一生患病人數
    • 一生患病人數的明細:重症度別
  • 考察
    • 流行病學的趨勢相關結論
    • 分析的限制
    • 分析的優勢

第4章 附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHCER089-15

Atopic dermatitis or atopic eczema is the most common type of eczema. Atopic dermatitis is a chronic inflammatory skin disease characterized by itchy skin lesions and rashes. Though the condition affects people of all ages, it is primarily common among infants and children. Risk factors for atopic dermatitis are broadly classified as modifiable and non-modifiable. Modifiable risk factors include inhalant allergens, food allergens, and newborns not being exclusively breastfed; non-modifiable risk factors include young age and genetics or heritability. In addition, the most common comorbidities associated with the atopic dermatitis such as atopic disorders and psychological disorders contribute significantly to the clinical occurrence of atopic dermatitis.

GlobalData epidemiologists forecast that the one-year total prevalent cases of atopic dermatitis in the 9MM will increase from 66,289,178 cases in 2014 to 67,630,097 cases in 2024 with an annual growth rate (AGR) of 0.20%. In the 9MM, India will have the highest number of one-year total prevalent cases of atopic dermatitis with 23,496,094 cases in 2024, followed by the US and China.

GlobalData epidemiologists forecast the prevalent cases of atopic dermatitis in the 9MM from 2014-2024 using country-specific studies that provided one-year total prevalence of atopic dermatitis in these markets obtained through symptom-based surveys. Furthermore, GlobalData epidemiologists selected nationally representative studies that provided data on distribution of atopic dermatitis severity in the 9MM. Moreover, GlobalData epidemiologists made sure that the selected nationally representative and country-specific studies assessed the atopic dermatitis prevalence, based on active symptoms during the past year in these markets.

Scope

  • The Atopic Dermatitis EpiCast Report provides an overview of the risk factors, comorbidities, and global trends for atopic dermatitis in the nine major markets (9MM) (US, France, Germany, Italy, Spain, UK, Japan, China, and India). It includes a 10-year epidemiological forecast of the one-year prevalent cases of atopic dermatitis segmented by sex, age (in one-year increments beginning at 0 and ending at 19 years and also in five-year increments beginning at 20 years and ending at =85 years), and severity in these markets.
  • The Atopic Dermatitis epidemiology report is written and developed by Masters- and PhD-level epidemiologists.
  • The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 10MM.

Reasons to buy

The Atopic Dermatitis EpiCast report will allow you to -

  • Develop business strategies by understanding the trends shaping and driving the global atopic dermatitis market.
  • Quantify patient populations in the global atopic dermatitis market to improve product design, pricing, and launch plans.
  • Organize sales and marketing efforts by identifying the sex and age groups that present the best opportunities for atopic dermatitis therapeutics in each of the markets covered.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Catalyst
  • 2.2. Related Reports
  • 2.3. Upcoming Related Reports

3. Epidemiology

  • 3.1. Disease Background
  • 3.2. Risk Factors and Comorbidities
  • 3.3. Global Trends
    • 3.3.1. US
    • 3.3.2. France
    • 3.3.3. Germany
    • 3.3.4. Italy
    • 3.3.5. Spain
    • 3.3.6. UK
    • 3.3.7. Japan
    • 3.3.8. China
    • 3.3.9. India
  • 3.4. Forecast Methodology
    • 3.4.1. Sources Used
    • 3.4.2. Sources Not Used
    • 3.4.3. Forecast Assumptions and Methods
  • 3.5. Epidemiological Forecast for Atopic Dermatitis (2014-2024)
    • 3.5.1. One-Year Total Prevalent Cases of Atopic Dermatitis
    • 3.5.2. Age-Specific One-Year Total Prevalent Cases of Atopic Dermatitis
    • 3.5.3. Sex-Specific One-Year Total Prevalent Cases of Atopic Dermatitis
    • 3.5.4. Age-Standardized One-Year Total Prevalence of Atopic Dermatitis
    • 3.5.5. One-Year Total Prevalent Cases of Atopic Dermatitis by Severity
  • 3.6. Discussion
    • 3.6.1. Epidemiological Forecast Insight
    • 3.6.2. Limitations of the Analysis
    • 3.6.3. Strengths of the Analysis

4. Appendix

  • 4.1. Bibliography
  • 4.2. About the Authors
    • 4.2.1. Epidemiologists
    • 4.2.2. Reviewers
    • 4.2.3. Global Director of Therapy Analysis and Epidemiology
    • 4.2.4. Global Head of Healthcare
  • 4.3. About GlobalData
  • 4.4. About EpiCast
  • 4.5. Disclaimer

List of Tables

  • Table 1: Risk Factors and Comorbidities of Atopic Dermatitis
  • Table 2: Diagnostic Criteria for Atopic Dermatitis
  • Table 3: The Hanifin and Rajka Diagnostic Criteria for Atopic Dermatitis
  • Table 4: 9MM, Sources of Epidemiological Data Used for the Forecast for the One-Year Total Prevalent Cases of Atopic Dermatitis
  • Table 5: 9MM, Sources of Epidemiological Data Used for the Segmentation of One-Year Total Prevalent Cases of Atopic Dermatitis by Severity
  • Table 6: 9MM, One-Year Total Prevalent Cases of Atopic Dermatitis, All Ages, Both Sexes, N, 2014-2024
  • Table 7: 9MM, One-Year Total Prevalent Cases of Atopic Dermatitis, by Age Group, Both Sexes, N, (Row %), 2014
  • Table 8: 9MM, One-Year Total Prevalent Cases of Atopic Dermatitis, by Sex, All Ages, N (Row %), 2014
  • Table 9: 9MM, One-Year Total Prevalent Cases of Atopic Dermatitis by Severity, All Ages, Both Sexes, N (Row %), 2014

List of Figures

  • Figure 1: 9MM, One-Year Total Prevalent Cases of Atopic Dermatitis, All Ages, Both Sexes, N, 2014-2024
  • Figure 2: 9MM, One-Year Total Prevalent Cases of Atopic Dermatitis, by Age Group, Both Sexes, N, 2014
  • Figure 3: 9MM, One-Year Total Prevalent Cases of Atopic Dermatitis, by Sex, All Ages, N, 2014
  • Figure 4: 9MM, Age-Standardized One-Year Total Prevalence (%) of Atopic Dermatitis, All Ages, Both Sexes, 2014
  • Figure 5: 9MM, One-Year Total Prevalent Cases of Atopic Dermatitis by Severity, All Ages, Both Sexes, N, 2014
Back to Top